J. L. Italia

Biodegradable Nanoparticles Improve Oral Bioavailability of Amphotericin B and Show Reduced Nephrotoxicity Compared to Intravenous Fungizone®

J. L. Italia, Momenah M. Yahya, Desh Deepak Singh et al. · Pharmaceutical Research · 2009 · 145 citations

Pharmacy, Clinical Pharmacokinetics, Pharmaceutics +17

Peroral Amphotericin B Polymer Nanoparticles Lead to Comparable or Superior In Vivo Antifungal Activity to That of Intravenous Ambisome® or Fungizone™

J. L. Italia, Katharine C. Carter, Peter Warn et al. · PLoS ONE · 2011 · 57 citations · Full text

Pharmacy, Molecular Pharmaceutics, Pharmaceutics +17

The efficacy of aerosol treatment with non-ionic surfactant vesicles containing amphotericin B in rodent models of leishmaniasis and pulmonary aspergillosis infection

J. L. Italia, Alexander B. Mullen, M. N. V. Ravi Kumar et al. · Journal of Controlled Release · 2012 · 50 citations

Pharmacy, Infectious Diseases, Pharmacokinetics +17

Evaluating the Potential of Polyester Nanoparticles for Per Oral Delivery of Amphotericin B in Treating Visceral Leishmaniasis

J. L. Italia, M. N. V. Ravi Kumar, K C Carter · Journal of Biomedical Nanotechnology · 2012 · 42 citations

Pharmacy, Pharmaceutics, Pharmacology +17

Nanoparticles Enhance <I>Per Oral</I> Bioavailability of Poorly Available Molecules: Epigallocatechin Gallate Nanoparticles Ameliorates Cyclosporine Induced Nephrotoxicity in Rats at Three Times Lower Dose Than Oral Solution

J. L. Italia, P.K. Datta, D. D. Ankola et al. · Journal of Biomedical Nanotechnology · 2008 · 40 citations

Pharmacy, Pharmaceutics, Pharmacology +17